Figure 1 (Hemacord Figure 1)
Hemacord
Product Images NDC 76489-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Hemacord (NDC 76489-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by New York Blood Center, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 9 (Hemacord Figure 10)
This text is too short to generate a useful description. It appears to be a fragment of a phrase or sentence, without any additional context. Therefore, the description cannot be determined.*
Package Label (25 mL Bag)
This is a description of a frozen sample of cord blood from HPC, stored at a temperature of -150°C and not irradiated. The sample was prepared with 10% DMSO and 1% Dexiran 40 and labeled verifiably stored at -160°C. The sample was obtained from the New York Blood Center Inc. located at 45-01 Vernon Boulevard in Long Island City, New York, USA.*
Package Label (25 mL Canister)
The given text seems to be a general description of a medical product named "HEMACORD" from "New York Blood Center, Inc.". The product is frozen with 10% DMSO and 1% Dextran 40 and it is advised not to be irradiated. The product can be shipped and stored at a temperature below -150°C. The text also includes the license number of the product, which is "0465".*
Package Label (NDC 76489-001-01)
This is a description of a Hemacord injectable suspension, an HPC cord blood product. It contains a Hemacord ID, NDC code, and recipient information, including a tissue group number and LA match. It is for intravenous administration only and has an expiration date of 10112020. The text also includes a warning about the product and information about the licensing and supplier organization.*
Figure 2. (Hemacord Figure 2)
Figure 3 (Hemacord Figure 3)
Figure 4a (Hemacord Figure 4)
Figure 4b (Hemacord Figure 5)
Figure 5 (Hemacord Figure 6)
Figure 6. (Hemacord Figure 7)
Figure 7 (Hemacord Figure 8)
Figure 8 (Hemacord Figure 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
